Abstract
This chapter illustrates diseases that involve the peripheral nervous system and skeletal muscle. In such diseases, history and physical examination frequently provide sufficient data to arrive at the correct diagnosis. For example, autonomic dysfunction, distal limb weakness, hyporeflexia, and sensory loss in an adult with long-standing diabetes mellitus are probably due to diabetic neuropathy, and fluctuating weakness of bulbar and ocular muscles without sensory or reflex alterations strongly suggests myasthenia gravis. The clinical diagnosis can often be validated by specific immunochemical, biochemical, or molecular blood tests, as in the common scenario of polyneuropathy (Table 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology. 1999;53:1634–40.
Asbury AK, Gilliatt RW. The clinical approach to neuropathy. In: Asbury AK, Gilliatt RW, editors. Peripheral nerve disorders. London: Butterworths; 1994. p. 1–20.
Lennon VA, Kryzer TJ, Griesmann GE, O’Suilleabhain PE, Windebank AJ, Woppmann A, et al. Calcium channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med. 1995;332:1467–74.
Chaudhry V, Crawford TO. Stimulation single-fiber EMG in infant botulism. Muscle Nerve. 1999;22:1698–703.
Le Rumeur E, Winder SJ, Hubert JF. Dystrophin: more than just the sum of its parts. Biochim Biophys Acta. 2010;1804:1713–22.
Nigro V, Piluso G. Spectrum of muscular dystrophies associated with sarcolemmal-protein genetic defects. Biochim Biophys Acta. 2015;1852:585–93.
Wheeler TM, Sobczak K, Lueck JD, Osborne RJ, Lin X, Dirksen RT, Thornton CA. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science. 2009;325:336–9.
Lieberman AP, Fischbeck KH. Triplet repeat expansion in neuromuscular disease. Muscle Nerve. 2000;23:843–50.
Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camaño P, Dauwerse JG, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science. 2010;329:1650–3.
DiMauro S, Bonilla E, Davidson M, Hirano M, Schon EA. Mitochondria in neuromuscular disorders. Biochim Biophys Acta. 1998;1366:199–210.
Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C, et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet. 1995;9:75–9.
Romero NB, Monnier N, Viollet L, Cortey A, Chevallay M, Leroy JP, et al. Dominant and recessive central core disease associated with RyR1 mutations and fetal akinesia. Brain. 2003;126:2341–9.
North KN. Clinical approach to the diagnosis of congenital myopathies. Semin Pediatr Neurol. 2011;18:216–20.
Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med. 1992;326:363–7.
Dimachkie MM, Barohn RJ. Inclusion body myositis. Semin Neurol. 2012;32:237–45.
Adams D, Samuel D, Goulon-Goeau C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain. 2000;123:1495–504.
Klein CJ. The inherited neuropathies. Neurol Clin. 2007;25:173–207.
La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet. 1992;2:301–4.
Pellizzoni L, Charroux B, Dreyfuss G. SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc Natl Acad Sci U S A. 1999;96:11167–72.
Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603–15.
Peters A, Palay SL, Webster H deF. The fine structure of the nervous system. New York: Oxford University Press; 1994.
Khella SL, Frost S, Hermann GA, Leventhal L, Whyatt S, Sajid MA, et al. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy: treatment with interferon alpha: case report and literature review. Neurology. 1995;45:407–11.
Rajkumar SV, Gertz MA, Kyle RA. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med. 1998;104:232–7.
Arroyo EJ, Scherer SS. On the molecular architecture of myelinated fibers. Histochem Cell Biol. 2000;113:1–18.
Nobile-Orazio E, Meucci N, Baldini L, Di Troia A, Scarlato G. Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain. 2000;123:710–7.
Kirschner J, Bönnemann CG. The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundaries. Arch Neurol. 2004;61:189–99.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wolfe, G.I., Balos, L.L., Fine, E.J., Bönnemann, C.G., Silvestri, N.J. (2019). Neuromuscular Disease. In: Rosenberg, R. (eds) Atlas of Clinical Neurology. Springer, Cham. https://doi.org/10.1007/978-3-030-03283-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-03283-8_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03281-4
Online ISBN: 978-3-030-03283-8
eBook Packages: MedicineMedicine (R0)